Trichophagia Affects Response to Duodenal Levodopa/Carbidopa Gel AdministrationMÜLLER, Thomas; HAAS, Thomas; LÜTGE, Sven et al.Movement disorders. 2012, Vol 27, Num 4, pp 588-590, issn 0885-3185, 3 p.Article

Severe Gastrointestinal Complications in Patients With Levodopa/Carbidopa Intestinal Gel InfusionKLOSTERMANN, Fabian; JUGEL, Constanze; BÖMELBURG, Miriam et al.Movement disorders. 2012, Vol 27, Num 13, pp 1704-1705, issn 0885-3185, 2 p.Article

The hydrosoluble fiber Plantago ovata husk improves levodopa (with carbidopa) bioavailability after repeated administrationDIEZ, M. Jose; GARCIA, Juan J; PRIETO, Carlos et al.Journal of the neurological sciences. 2008, Vol 271, Num 1-2, pp 15-20, issn 0022-510X, 6 p.Article

L'ALPHA-METHYLDOPA HYDRAZINE (CARBIDOPA) COMBINED WITH L-DOPA IN THE TREATMENT OF PARKINSON'S DISEASE = L'HYDRAZINE DE LA L-ALPHA -METHYLDOPA (CARBIDOPA) ASSOCIEE A LA L-DOPA DANS LE TRAITEMENT DE LA MALADIE DE PARKINSONGLASGOW GL; HENLEY JW; WILLOUGHBY EW et al.1974; AUSTRAL. NEW ZEAL. J. MED.; AUSTRAL.; DA. 1974; VOL. 4; NO 4; PP. 373-378; BIBL. 24REF.Article

THERAPY OF INTENTION MYOCLONUS WITH L-5-HYDROXYTRYPTOPHAN AND A PERIPHERAL DECARBOXYLASE INHIBITOR, MK486 = TRAITEMENT DU MYOCLONUS INTENTIONNEL PAR LE L-5 HYDROXYTRYPTOPHANE ET UN INHIBITEUR DE LA DECARBOXYLASE PERIPHERIQUE, LE MK486VAN WOERT MH; SETHY VH.1975; NEUROLOGY; U.S.A.; DA. 1975; VOL. 25; NO 2; PP. 135-140; BIBL. 35REF.Article

Kinetic Characterization of the Oxidation of Carbidopa and Benserazide by Tyrosinase and PeroxidaseMUNOZ-MUNOZ, Joseph Louis; GARCIA-MOLINA, Francis; GARCIA-MOLINA, Mary et al.Bioscience, biotechnology, and biochemistry. 2009, Vol 73, Num 6, pp 1308-1313, issn 0916-8451, 6 p.Article

Simultaneous determination of levodopa and carbidopa by synchronous fluorescence spectrometry using double scansWOOK HYUN KIM; MOHAMMAD MAINUL KARIM; SANG HAK LEE et al.Analytica chimica acta. 2008, Vol 619, Num 1, pp 2-7, issn 0003-2670, 6 p.Conference Paper

STUDIES ON DL-5-HYDROXYTRYPTOPHAN-INDUCED HYPERACTIVITY IN MICE = ETUDES SUR L'HYPERACTIVITE INDUITE PAR LE DL-5-HYDROXYTRYPTOPHANE CHEZ LES SOURISMODIGH K.1974; ADV. BIOCHEM. PSYCHOPHARMACOL.; U.S.A.; DA. 1974; VOL. 10; PP. 213-217; BIBL. 10REF.Article

Carbidopa dosage modifies L-DOPA induced side effects and blood levels of L-DOPA and other aminoacids in advanced parkinsonismPAREJA, F. B; MARTINEZ-MARTIN, P; MURADAS, V et al.Acta neurologica scandinavica. 1985, Vol 72, Num 5, pp 506-511, issn 0001-6314Article

Use of integral and differential methods for the determination of L-dopa in pure form and pharmaceutical preparationsHELALEH, M. I. H; RAHMAN, N; JAMHOUR, R. M. A. Q et al.Journal of pharmaceutical and biomedical analysis. 1997, Vol 16, Num 2, pp 269-274, issn 0731-7085Article

The effect of tolcapone on levodopa pharmacokinetics is independent of levodopa/carbidopa formulationJORGA, K; FOTTELER, B; SEDEK, G et al.Journal of neurology. 1998, Vol 245, Num 4, pp 223-230, issn 0340-5354Article

Hyperdopaminergic crises in familial dysautonomia: A randomized trial of carbidopaNORCLIFFE-KAUFMANN, Lucy; MARTINEZ, Jose; AXELROD, Felicia et al.Neurology. 2013, Vol 80, Num 17, pp 1611-1617, issn 0028-3878, 7 p.Article

Long-term follow-up of L-dopa treatment in children with amblyopiaLEGUIRE, Lawrence E; KOMAROMY, Kelly L; NAIRUS, Theresa M et al.Journal of pediatric ophthalmology and strabismus. 2002, Vol 39, Num 6, pp 326-330, issn 0191-3913, 5 p.Article

Carbidopa/levodopa for smoking cessation: a pilot study with negative resultsHURT, R. D; AHLSKOG, J. E; CROGHAN, G. A et al.Nicotine & tobacco research. 2000, Vol 2, Num 1, pp 71-78, issn 1462-2203Article

Effects of carbidopa and of intravenous saline infusion into normal and hypertensive subjects on urinary free and conjugated dopamineSTOKES, G. S; MONAGHAN, J. C; PILLAI, D. N et al.Journal of hypertension. 1997, Vol 15, Num 7, pp 761-768, issn 0263-6352Article

Deceleration of light-induced changes of selected pharmacons by means of light screening filmsTURY, G; SZABO, G. T; VABRIK, R et al.Journal of photochemistry and photobiology. A, Chemistry. 1997, Vol 111, Num 1-3, pp 171-179, issn 1010-6030Article

Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease: The STRIDE-PD StudySTOCCHI, Fabrizio; RASCOL, Olivier; KIEBURTZ, Karl et al.Annals of neurology. 2010, Vol 68, Num 1, pp 18-27, issn 0364-5134, 10 p.Article

Blood-brain barrier and neuronal membrane transport of 6-[¹⁸F]fluoro-L-DOPAYEE, Randa E; CHENG, David W; HUANG, Sung-Cheng et al.Biochemical pharmacology. 2001, Vol 62, Num 10, pp 1409-1415, issn 0006-2952Article

PSYCHIATRIC SYMPTOMS DURING L-DOPA THERAPY FOR PARKINSON'S DISEASE AND THEIR RELATIONSHIP TO PHYSICAL DISABILITY = SYMPTOMES PSYCHIATRIQUES AU COURS D'UN TRAITEMENT DE L-DOPA POUR LA MALADIE DE PARKINSON: LEURS RELATIONS AVEC LE TROUBLE PHYSIQUEMINDHAM RHS; MARSDEN CD; PARKES D et al.1976; PSYCHOL. MED.; G.B.; DA. 1976; VOL. 6; NO 1; PP. 23-33; BIBL. 1 P.Article

FURTHER STUDIES ON THE METABOLISM OF CARBIDOPA, (-)-L-ALPHA -HYDRAZINO-3,4-DIHYDROXY-ALPHA -METHYL BENZENE PROPANOIC ACID MONOHYDRATE, IN THE HUMAN, RHESUS MONKEY, DOG, AND RATVICKERS S; STUART EK; HUCKER HB et al.1975; J. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 18; NO 2; PP. 134-138; BIBL. 19 REF.Article

RESULTADOS OBTENIDOS MEDIANTE LA ASOCIACION LEVODOPA-CARBIDOPA EN 36 ENFERMOS PARKINSONIANOS, DESPUES DE 20 SEMANAS DE TRATAMIENTO = RESULTATS OBTENUS AU MOYEN DE L'ASSOCIATION LEVODOPA-CARBIDOPA CHEZ 36 MALADES PARKINSONIENS, APRES 20SEMAINES DE TRAITEMENTBARRAQUER BORDAS L; BLESA R; SABIDO F et al.1975; MED. CLIN.; ESP.; DA. 1975; VOL. 64; NO 9; PP. 478-482; ABS. ANGL.; BIBL. 4REF.Article

TREATMENT OF PARKINSON'S DISEASE WITH CARBIDOPA, A PERIPHERAL DECARBOXYLASE INHIBITOR, AND LEVODOPAFERMAGLICH J.1974; MED. ANN. DISTR. COLUMBIA; U.S.A.; DA. 1974; VOL. 43; NO 12; PP. 587-591; BIBL. 36REF.Article

Metabolism of carbidopa to alpha-methyldopamine and alpha-methylnorepinephrine in ratsSHELTON, R. C; FAROUK KAROUM; LIN-WHEI CHUANG et al.Biochemical pharmacology. 1985, Vol 34, Num 20, pp 3623-3626, issn 0006-2952Article

Design and optimization of a chemometrics-assisted spectrophotometric method for the simultaneous determination of levodopa and carbidopa in pharmaceutical productsDAMIANI, Patricia C; MOSCHETTI, Andrea C; ROVETTO, Adrian J et al.Analytica chimica acta. 2005, Vol 543, Num 1-2, pp 192-198, issn 0003-2670, 7 p.Article

¹H nuclear magnetic resonance spectroscopy analysis for simultaneous determination of levodopa, carbidopa and methyldopa in human serum and pharmaceutical formulationsTALEBPOUR, Zahra; HAGHGOO, Soheila; SHAMSIPUR, Mojtaba et al.Analytica chimica acta. 2004, Vol 506, Num 1, pp 97-104, issn 0003-2670, 8 p.Article